1. Home
  2. WLYB vs LIVN Comparison

WLYB vs LIVN Comparison

Compare WLYB & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLYB
  • LIVN
  • Stock Information
  • Founded
  • WLYB 1807
  • LIVN 1987
  • Country
  • WLYB United States
  • LIVN United Kingdom
  • Employees
  • WLYB N/A
  • LIVN N/A
  • Industry
  • WLYB Books
  • LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • WLYB Consumer Discretionary
  • LIVN Health Care
  • Exchange
  • WLYB Nasdaq
  • LIVN Nasdaq
  • Market Cap
  • WLYB 2.3B
  • LIVN 2.1B
  • IPO Year
  • WLYB N/A
  • LIVN 1993
  • Fundamental
  • Price
  • WLYB $44.00
  • LIVN $44.06
  • Analyst Decision
  • WLYB
  • LIVN Buy
  • Analyst Count
  • WLYB 0
  • LIVN 7
  • Target Price
  • WLYB N/A
  • LIVN $58.57
  • AVG Volume (30 Days)
  • WLYB 199.0
  • LIVN 882.2K
  • Earning Date
  • WLYB 06-12-2025
  • LIVN 05-07-2025
  • Dividend Yield
  • WLYB 3.21%
  • LIVN N/A
  • EPS Growth
  • WLYB N/A
  • LIVN N/A
  • EPS
  • WLYB 0.75
  • LIVN N/A
  • Revenue
  • WLYB $1,703,491,000.00
  • LIVN $1,275,380,000.00
  • Revenue This Year
  • WLYB N/A
  • LIVN $5.79
  • Revenue Next Year
  • WLYB $1.13
  • LIVN $5.51
  • P/E Ratio
  • WLYB $58.26
  • LIVN N/A
  • Revenue Growth
  • WLYB N/A
  • LIVN 7.62
  • 52 Week Low
  • WLYB $35.68
  • LIVN $32.48
  • 52 Week High
  • WLYB $52.90
  • LIVN $64.48
  • Technical
  • Relative Strength Index (RSI)
  • WLYB 65.28
  • LIVN 70.16
  • Support Level
  • WLYB $39.54
  • LIVN $35.00
  • Resistance Level
  • WLYB $44.15
  • LIVN $37.95
  • Average True Range (ATR)
  • WLYB 0.01
  • LIVN 1.30
  • MACD
  • WLYB 0.11
  • LIVN 1.06
  • Stochastic Oscillator
  • WLYB 86.96
  • LIVN 91.36

About WLYB John Wiley & Sons Inc.

John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

About LIVN LivaNova PLC

UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: